drugset / Trial / NCT02252796
Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will help researchers test the safety of hypofractionated dose of radiotherapy (HySBst) at different dose levels before or after chemo-radiation for Non Small Cell Lung Cancer.
Timeline
- Start
- 2014-07
- Primary completion
- 2017-09
- Completion
- 2017-09
Outcome
Outcome not reported
Stopped: “Investigator left institution”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Carboplatin | Small molecule | 2 unknown | — |
| Background | Carboplatin | Small molecule | 6 unknown | — |
| Background | Paclitaxel | Small molecule | 45 mg/m2 | — |
| Background | Paclitaxel | Small molecule | 200 mg/m2 | — |